OrganiGram Historical Income Statement
| OGI Stock | USD 1.51 0.03 2.03% |
Historical analysis of OrganiGram Holdings income statement accounts such as Total Operating Expenses of 327.8 M can show how well OrganiGram Holdings performed in making a profits. Evaluating OrganiGram Holdings income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of OrganiGram Holdings's future profits or losses.
Financial Statement Analysis is much more than just reviewing and examining OrganiGram Holdings latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether OrganiGram Holdings is a good buy for the upcoming year.
OrganiGram |
About OrganiGram Income Statement Analysis
OrganiGram Holdings Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to OrganiGram Holdings shareholders. The income statement also shows OrganiGram investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).
OrganiGram Holdings Income Statement Chart
Add Fundamental
Other Operating Expenses
Other Operating Expenses is the expense which generally does not depend on sales or production quantities of OrganiGram Holdings. It is also known as OrganiGram Holdings overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.Operating Income
Operating Income is the amount of profit realized from OrganiGram Holdings operations after accounting for operating expenses such as cost of goods sold (COGS), wages and depreciation. Operating income takes the gross income and subtracts other operating expenses and then removes depreciation. Operating Income of OrganiGram Holdings is typically a synonym for earnings before interest and taxes (EBIT) and is also commonly referred to as operating profit or recurring profit. Earnings before interest and taxes (EBIT), representing the amount of profit a company generates from its operations.Total Operating Expenses
The total costs associated with the day-to-day operations of a business, excluding the cost of goods sold but including selling, general, and administrative expenses.Most accounts from OrganiGram Holdings' income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into OrganiGram Holdings current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in OrganiGram Holdings. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price. For more detail on how to invest in OrganiGram Stock please use our How to Invest in OrganiGram Holdings guide.As of now, OrganiGram Holdings' Income Tax Expense is increasing as compared to previous years. The OrganiGram Holdings' current Depreciation And Amortization is estimated to increase to about 28.3 M, while Interest Expense is projected to decrease to under 303.5 K.
| 2023 | 2024 (projected) | Reconciled Depreciation | 28.6M | 16.1M | Interest Income | 11.8M | 12.4M |
OrganiGram Holdings income statement Correlations
Click cells to compare fundamentals
OrganiGram Holdings Account Relationship Matchups
High Positive Relationship
High Negative Relationship
OrganiGram Holdings income statement Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Interest Expense | 6.0M | 3.0M | 429K | 277.8K | 319.5K | 303.5K | |
| Selling General Administrative | 29.9M | 30.7M | 42.4M | 49.0M | 56.3M | 59.1M | |
| Other Operating Expenses | 184.7M | 152.0M | 184.6M | 385.6M | 443.5M | 465.6M | |
| Operating Income | (145.5M) | (91.8M) | (38.8M) | (48.8M) | (43.9M) | (41.7M) | |
| Ebit | (140.6M) | (74.0M) | (40.1M) | (48.8M) | (43.9M) | (41.7M) | |
| Ebitda | (122.7M) | (42.9M) | (15.2M) | (25.4M) | (22.8M) | (21.7M) | |
| Total Operating Expenses | 41.4M | 44.4M | 70.3M | 271.5M | 312.2M | 327.8M | |
| Income Before Tax | (146.6M) | (130.7M) | (14.4M) | (233.0M) | (209.7M) | (199.2M) | |
| Net Income | (136.2M) | (132.5M) | (14.3M) | (229.5M) | (206.5M) | (196.2M) | |
| Income Tax Expense | (10.5M) | 1.8M | (88K) | 3.5M | 4.0M | 4.2M | |
| Total Other Income Expense Net | (47.0M) | (38.9M) | 24.4M | (184.2M) | (165.8M) | (157.5M) | |
| Depreciation And Amortization | 18.0M | 31.0M | 24.9M | 23.4M | 26.9M | 28.3M | |
| Selling And Marketing Expenses | 16.5M | 15.8M | 16.9M | 17.9M | 20.5M | 10.3M | |
| Total Revenue | 86.8M | 79.2M | 145.8M | 149.2M | 171.6M | 180.2M | |
| Gross Profit | (56.5M) | (28.4M) | 31.6M | 35.1M | 40.3M | 42.4M | |
| Cost Of Revenue | 143.3M | 107.6M | 114.2M | 114.1M | 131.3M | 137.8M | |
| Net Income From Continuing Ops | (9.5M) | (136.2M) | (130.7M) | (14.3M) | (12.9M) | (13.5M) | |
| Research Development | 1.3M | 3.5M | 6.0M | 12.2M | 14.0M | 14.7M | |
| Net Income Applicable To Common Shares | (136.2M) | (130.7M) | (14.3M) | (229.5M) | (206.5M) | (196.2M) | |
| Net Interest Income | (9.7M) | (6.0M) | (3.0M) | (429K) | (386.1K) | (405.4K) | |
| Reconciled Depreciation | 8.9M | 18.0M | 31.0M | 24.9M | 28.6M | 16.1M | |
| Tax Provision | 3.6M | (10.5M) | 0.0 | (88K) | (79.2K) | (83.2K) |
Currently Active Assets on Macroaxis
When determining whether OrganiGram Holdings offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of OrganiGram Holdings' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Organigram Holdings Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Organigram Holdings Stock:Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in OrganiGram Holdings. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price. For more detail on how to invest in OrganiGram Stock please use our How to Invest in OrganiGram Holdings guide.You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of OrganiGram Holdings. If investors know OrganiGram will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about OrganiGram Holdings listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.83) | Revenue Per Share 1.835 | Quarterly Revenue Growth (0.14) | Return On Assets (0.06) | Return On Equity (0.55) |
The market value of OrganiGram Holdings is measured differently than its book value, which is the value of OrganiGram that is recorded on the company's balance sheet. Investors also form their own opinion of OrganiGram Holdings' value that differs from its market value or its book value, called intrinsic value, which is OrganiGram Holdings' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because OrganiGram Holdings' market value can be influenced by many factors that don't directly affect OrganiGram Holdings' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between OrganiGram Holdings' value and its price as these two are different measures arrived at by different means. Investors typically determine if OrganiGram Holdings is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, OrganiGram Holdings' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.